{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:48:53Z","timestamp":1787766533388,"version":"build-2784847793"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"abstract":"<jats:p>Bladder cancer (BC) is a significant global health issue with high incidence and mortality rates. MicroRNAs (miRNAs) play a crucial role in regulating gene expression and have been found to be dysregulated in BC. Understanding the role of miRNAs in BC development could lead to targeted therapies and improved patient management. Our study presents a thorough examination of the correlation between BC and miRNA research from 2008 to 2022. With the help of 3 powerful methods, including VOSviewer, Biblioshiny, and CiteSpace software, we analyzed the retrieved documents from \u201cCore Collection databases online\u201d on the Web of Science. In total, 798 articles were extracted from the Web of Science, and the number of published papers showed an upward trend from 2008 to 2019. The total number of citations was 21,233, of which the highest paper was a review article written by Chan Jiajia et al in 2018 with 752 citations. Based on the result of the coauthor analysis, Seki Naohiko was the most productive writer and China had the highest volume of published articles. Co-citation analysis was used to reveal the knowledge structure of the research field. In addition to the keywords \u201cBladder cancer\u201d and \u201cmiRNA,\u201d \u201cProliferation,\u201d \u201cBiomarkers,\u201d and \u201cApoptosis\u201d were the high-frequency used keywords. Recently, increasingly researchers have paid more attention to the field about BC and miRNA around the worldwide. Through in-depth communication and close collaboration, the veil of miRNA in BC has gradually been unveiled. Bibliometric analysis helps to identify hotspots in research and areas for future investigation.<\/jats:p>","DOI":"10.1097\/md.0000000000040289","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:04:53Z","timestamp":1730214293000},"page":"e40289","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["A bibliometric analysis of bladder cancer and microRNA research: Trends and advances from 2008 to 2022"],"prefix":"10.1097","volume":"103","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaowei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinji","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexian","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peidong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqi","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuncheng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8107-4855","authenticated-orcid":false,"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Jieyang People\u2019s Hospital, Jieyang, Guangdong, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review.","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020.","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R4-20250504","article-title":"Bladder cancer: current challenges and future directions.","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R5-20250504","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022.","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.NPR.0000512251.61454.5c","article-title":"Bladder cancer: risk factors, diagnosis, and management.","volume":"42","author":"Farling","year":"2017","journal-title":"Nurse Pract"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","article-title":"Recurrence mechanisms of non-muscle-invasive bladder cancer\u2014a clinical perspective.","volume":"19","author":"Teoh","year":"2022","journal-title":"Nat Rev Urol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/bib\/bby054","article-title":"Trends in the development of miRNA bioinformatics tools.","volume":"20","author":"Chen","year":"2019","journal-title":"Brief Bioinform"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA.","volume":"141","author":"Lu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R10-20250504","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.047662","article-title":"miRNA interplay: mechanisms and consequences in cancer.","volume":"14","author":"Hill","year":"2021","journal-title":"Dis Model Mech"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer.","volume":"4","author":"Lee","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2147\/IJN.S72904","article-title":"Clinical and pathological implications of miRNA in bladder cancer.","volume":"10","author":"Braicu","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12032-020-01435-0","article-title":"MicroRNAs and target molecules in bladder cancer.","volume":"37","author":"Parizi","year":"2020","journal-title":"Med Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping.","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"bibliometrix: an R-tool for comprehensive science mapping analysis.","volume":"11","author":"Aria","year":"2017","journal-title":"J Informetr"},{"key":"R16-20250504","first-page":"724","article-title":"CiteSpace II: visualization and knowledge discovery in bibliographic databases.","volume":"2005","author":"Synnestvedt","year":"2005","journal-title":"AMIA Annu Symp Proc"},{"key":"R17-20250504","first-page":"980","article-title":"Web of science: a unique method of cited reference searching.","volume":"96","author":"Sevinc","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/ijms19051310","article-title":"Noncoding RNA:RNA regulatory networks in cancer.","volume":"19","author":"Chan","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.15252\/embr.201643581","article-title":"CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells.","volume":"18","author":"Li","year":"2017","journal-title":"EMBO Rep"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.biocel.2009.12.014","article-title":"MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.","volume":"42","author":"Cho","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"16569","DOI":"10.1073\/pnas.0507655102","article-title":"An index to quantify an individual\u2019s scientific research output.","volume":"102","author":"Hirsch","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.joi.2010.07.002","article-title":"A unified approach to mapping and clustering of bibliometric networks.","volume":"4","author":"Waltman","year":"2010","journal-title":"J Informetr"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1158\/0008-5472.CAN-08-4043","article-title":"Genomic profiling of MicroRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.","volume":"69","author":"Dyrskj\u00f8t","year":"2009","journal-title":"Cancer Res"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function.","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ijc.27949","article-title":"microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.","volume":"132","author":"Pignot","year":"2013","journal-title":"Int J Cancer"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009.","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.24390","article-title":"Identification of novel microRNA targets based on microRNA signatures in bladder cancer.","volume":"125","author":"Ichimi","year":"2009","journal-title":"Int J Cancer"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends.","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/09737766.2018.1436951","article-title":"Occurrence of author keywords and keywords plus in social sciences and humanities research: a preliminary study.","volume":"12","author":"Tripathi","year":"2018","journal-title":"Collnet J Scientometrics Inf Manage"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.","volume":"144","author":"Ferlay","year":"2018","journal-title":"Int J Cancer"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer.","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines.","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions.","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2174\/1871520618666180808125459","article-title":"Critical microRNAs in lung cancer: recent advances and potential applications.","volume":"18","author":"Zarredar","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"key":"R35-20250504","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04296-1","article-title":"LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review.","volume":"59","author":"Catto","year":"2011","journal-title":"Eur Urol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1158\/1078-0432.CCR-08-2245","article-title":"miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.","volume":"15","author":"Adam","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"e56102","DOI":"10.15252\/embr.202256102","article-title":"CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells.","volume":"23","author":"Li","year":"2022","journal-title":"EMBO Rep"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"30919","DOI":"10.1038\/srep30919","article-title":"Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p\/miR-107-CDK6 pathway in bladder carcinoma.","volume":"6","author":"Zhong","year":"2016","journal-title":"Sci Rep"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrurol.2013.113","article-title":"Aberrant expression of microRNAs in bladder cancer.","volume":"10","author":"Yoshino","year":"2013","journal-title":"Nat Rev Urol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10555-017-9692-y","article-title":"Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.","volume":"36","author":"Koshizuka","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jhg.2016.98","article-title":"MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.","volume":"62","author":"Mizuno","year":"2017","journal-title":"J Hum Genet"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3390\/cancers11101457","article-title":"c-Myc acts as a competing endogenous RNA to sponge miR-34a, in the upregulation of CD44, in urothelial carcinoma.","volume":"11","author":"Chen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/ijc.29413","article-title":"Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.","volume":"137","author":"Andrew","year":"2015","journal-title":"Int J Cancer"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"110703","DOI":"10.1016\/j.biopha.2020.110703","article-title":"Expression profile of microRNAs in bladder cancer and their application as biomarkers.","volume":"131","author":"Taheri","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"41.e1","DOI":"10.1016\/j.urolonc.2013.04.011","article-title":"Urine microRNAs as potential noninvasive biomarkers in urologic cancers.","volume":"32","author":"Mlcochova","year":"2014","journal-title":"Urol Oncol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.urolonc.2012.06.010","article-title":"Plasma microRNA profiles for bladder cancer detection.","volume":"31","author":"Adam","year":"2013","journal-title":"Urol Oncol"},{"key":"R49-20250504","first-page":"986","article-title":"miR-21 inhibits autophagy and promotes malignant development in the bladder cancer T24 cell line.","volume":"56","author":"Zhang","year":"2020","journal-title":"Int J Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:56:07Z","timestamp":1746320167000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":48,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040289","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}